Ascentage Pharma Group International (AAPG) Stock Price, News & Analysis

Company Overview

Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.

Key Stats

• Today's Range: $23.49 to $24.43
• 50-Day Range: $17.70 to $26.30
• 52-Week Range: $16.50 to $26.50
• Volume: 24,369 shs
• Average Volume: 67,780 shs
• Market Capitalization: $2.09 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Buy

AAPG Stock Analysis - Frequently Asked Questions

How have AAPG shares performed this year?

Ascentage Pharma Group International's stock was trading at $18.67 on January 1st, 2025. Since then, AAPG stock has increased by 28.8% and is now trading at $24.04.
View the best growth stocks for 2025 here.

When did Ascentage Pharma Group International IPO?

Ascentage Pharma Group International (AAPG) raised $126 million in an initial public offering (IPO) on Friday, January 24th 2025. The company issued 7,325,000 shares at $17.25 per share.

When does the company's lock-up period expire?

Ascentage Pharma Group International's lock-up period expires on Wednesday, July 23rd. Ascentage Pharma Group International had issued 7,325,000 shares in its initial public offering on January 24th. The total size of the offering was $126,356,250 based on an initial share price of $17.25. Shares of the company owned by major shareholders and company insiders will be eligible for trade following the expiration of the lock-up period.

How do I buy shares of Ascentage Pharma Group International?

Shares of AAPG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 5/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:AAPG
• Previous Symbol: NASDAQ:AAPG
• CIK: 2023311
• Web: N/A
• Phone: 86 512 8555 7777
• Fax: N/A
• Employees: 600
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $980.65 million
• Price / Sales: 2.13
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 87,068,000
• Free Float: N/A
• Market Cap: $2.09 billion
• Optionable: N/A
• Beta: N/A